Ugur Sahin and his wife Ozlem Tureci founded BioNTech in the city of Mainz, in western Germany, in 2008.
London:
If coronavirus vaccinations are widely rolled out, life could return to “normal” by next winter, one of the scientists behind the leading coronavirus vaccine said on Sunday.
Ugur Sahin, the Turkish co-founder of German company BioN, told the BBC’s Andrew Marr Show that “this winter will be tough” without any major impact from vaccinations.
In collaboration with the American giant Pfizer, BioN is developing the main candidate in the global search for a vaccine.
“If all goes well, we will start delivering the vaccine at the end of this year, or early next year,” Sahin said.
“Our goal is to deliver over 300 million doses by April next year, which could already have an impact,” he said.
The infection rate will then decrease in the summer, he predicted, adding that it is essential that the vaccination be widely used by the fall.
“I have no doubts it will happen,” he said.
A number of vaccination companies are working to increase supply, he said: “so that we can have a normal winter next (year).”
Sahin and his wife Ozlem Tureci founded BioNTech in the city of Mainz, in western Germany, in 2008.
After identifying promising vaccine plans, the company formed a partnership in March with US pharmaceutical giant Pfizer.
The announcement Monday that their vaccine was more than 90% effective in trials led to newsletters around the world and blew up stock markets and hopes.
BioNTech is now worth $ 25.8 billion (21.8 billion euros), more than the largest German lender Deutsche Bank.
(Except for the title, this story was not edited by GalacticGaming staff and is posted from a syndicated feed.)
